Insight Into the Recent Advancements in Thiazolidinedione Derivatives as PPAR-γ Agonists for the Treatment of Type 2 Diabetes.
INTRODUCTION Thiazolidinediones, commonly known as glitazones, serve as a vital biological framework in the treatment of type 2 diabetes. This established class of medications works by lowering insulin resistance and improving the body's ability to utilize glucose in peripheral tissues. They achieve this by activating...